Presentation TCT 2018 Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation Presenter: Davide Capodanno, Giulio Stefanini, Robert A. Byrne September 23, 2018
Presentation TCT 2018 US and ESC Guidelines and Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI Presenter: Davide Capodanno, Giulio Stefanini, Dominick J. Angiolillo September 23, 2018
Presentation TCT 2018 In 2018 When Is Warfarin Therapy Required vs Acceptable, and How Should it Be Dosed After PCI? Presenter: Davide Capodanno, Giulio Stefanini, Freek W.A. Verheugt September 23, 2018
Presentation TCT 2018 Has PIONEER and REDUAL Changed My Practice? What Are the Outstanding Issues? Presenter: Davide Capodanno, Giulio Stefanini, C. Michael Gibson September 23, 2018
Presentation TCT 2018 Pharmacotherapy Challenges and Possible Solutions in the PCI Patient on Chronic Oral Anticoagulation Presenter: Davide Capodanno, Giulio Stefanini, Tullio Palmerini September 23, 2018
Presentation TCT 2018 SORT OUT IX: Summary and Clinical Implications Presenter: Andreas Baumbach, Stephan Windecker, Lisette Okkels Jensen September 23, 2018
Presentation TCT 2018 LEADERS FREE II: Summary and Clinical Implications Presenter: Andreas Baumbach, Stephan Windecker, Mitchell W. Krucoff September 23, 2018
Presentation TCT 2018 COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng September 23, 2018
Presentation TCT 2018 Ultra-Short DAPT (1 3 Months): For Which Patients and Stents Do We Have Evidence? Presenter: Deepak L. Bhatt, Tullio Palmerini, Philip M. Urban September 23, 2018
Presentation TCT 2018 Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement? Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber September 23, 2018
Presentation TCT 2018 Who Is the High Bleeding Risk Patient, and How Should DAPT Duration Be Weighed Against Ischemic Risk? Presenter: Deepak L. Bhatt, Tullio Palmerini, Roxana Mehran September 23, 2018
Presentation TCT 2018 PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller September 23, 2018
Presentation TCT 2018 RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease Presenter: Fernando Alfonso, Juan F. Granada, Runlin Gao September 23, 2018
Presentation TCT 2018 RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen September 23, 2018
Presentation TCT 2018 BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent Presenter: Fernando Alfonso, Juan F. Granada, David E. Kandzari September 23, 2018
Presentation TCT 2018 I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Presenter: Michael Haude, Robert-Jan van Geuns, Yaling Han September 23, 2018
Presentation TCT 2018 NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold Presenter: Michael Haude, Robert-Jan van Geuns, Bo Xu September 23, 2018
Presentation TCT 2018 BIOSOLVE-IV: Twelve-Month Outcomes With a Resorbable Magnesium Scaffold in a Real-world Setting Presenter: Michael Haude, Robert-Jan van Geuns, Michael Kang-Yin Lee September 23, 2018
Presentation TCT 2018 RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold Presenter: Michael Haude, Robert-Jan van Geuns, Antonio Colombo September 23, 2018
Presentation TCT 2018 Flash Debate: Metallic BRS Have the Edge! Presenter: Ron Waksman September 22, 2018